Woolf CJ. Capturing novel non-opioid pain targets. Biol Psychiatry. 2020;87:74–81.
Gunn J, Hill MM, Cotten BM, Deer TR. An analysis of biomarkers in chronic pain patients. Pain Physician. 2020;23:E41–9.
Sun AL, Ni YH, Li XB, et al. Urinary methylmalonic acid as an indicator of early vitamin B12 deficiency and its role in polyneuropathy in type 2 diabetes. J Diabetes Res. 2014;2014:921616.
Diaz-Arrastia R. Homocysteine and neurologic disease. Arch Neurol. 2000;57:1422–8.
Vitamin B6 deficiency and tryptophan metabolism. NUTR REV. 2009; 21:89-91.
Carmella SG, Chen M, Zhang Y, Zhang S, Hatsukami DK, Hecht SS. Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking. Chem Res Toxicol. 2007;20:986–90.
Sforzini L, Nettis MA, Mondelli V, Pariante CM. Inflammation in cancer and depression: a starring role for the kynurenine pathway. Psychopharmacology. 2019;2(36):2997–3011.
Gamarra Y, Santiago FC, Molina-López J, et al. Pyroglutamic acidosis by glutathione regeneration blockage in critical patients with septic shock. Crit Care. 2019;23:162.
Accioly MF, Leite CF. Statin-induced myopathy. In: Travers ER, editor. Statins: medical uses, mechanisms of action and clinical outcomes, vol. 1. Hauppauge, NY: Nova Science Publishers; 2014. p. 183–95.
Réus GZ, Jansen K, Titus S, Carvalho AF, Gabbay V, Quevedo J. Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies. J Psychiatr Res. 2015;68:316–28.
Langan R, Goodbred A. Vitamin B12 deficiency: recognition and management. Am Fam Phys. 2017;96:384–9.
Gürsoy AE, Kolukısa M, Babacan-Yıldız G, Çelebi A. Subacute combined degeneration of the spinal cord due to different etiologies and improvement of MRI findings. Case Rep Neurol Med. 2013;2013:1–5.
Hammond N, Wang Y, Dimachkie MM, Barohn RJ. Nutritional neuropathies. Neurol Clin. 2013;31:477–89.
Heller CA, Friedman PA. Pyridoxine deficiency and peripheral neuropathy associated with long-term phenelzine therapy. Am J Med. 1983;75:887–8.
Raskin NH, Fishman RA. Pyridoxine-deficiency neuropathy due to hydralazine. N Engl J Med. 1965;273:1182–5.
Corken M, Porter J. Is vitamin B 6 deficiency an under-recognized risk in patients receiving haemodialysis? A systematic review: 2000-2010. Nephrology. 2011;16:619–25.
Ueland P, Mccann A, Midttun Ø, Ulvik A. Inflammation, vitamin B6 and related pathways. Mol Asp Med. 2017;53:10–27.
Kohlstadt I, editor. Food and nutrients in disease management. 1st ed. Boca Raton: CRC Press; 2009.
Kamat PK, Mallonee CJ, George AK, Tyagi SC, Tyagi N. Homocysteine, alcoholism, and its potential epigenetic mechanism. Alcohol Clin Exp Res. 2016;40:2474–81.
Morrow LE, Grimsley EW. Long-term diuretic therapy in hypertensive patients: effects on serum homocysteine, vitamin B6, vitamin B12, and red blood cell folate concentrations. South Med J. 1999;92:866–70.
Butler B, Acosta G, Shi R. Exogenous Acrolein intensifies sensory hypersensitivity after spinal cord injury in rat. J Neurol Sci. 2017;379:29–35.
Lin Y, Chen Z, Tang J, Cao P, Shi R. Acrolein contributes to the neuropathic pain and neuron damage after ischemic-reperfusion spinal cord injury. Neuroscience. 2018;384:120–30.
Moghe A, Ghare S, Lamoreau B, et al. Molecular mechanisms of acrolein toxicity: relevance to human disease. Toxicol Sci. 2015;143:242–55.
Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008;9:301–14.
Darmaun D, Smith SD, Sweeten S, Sager BK, Welch S, Mauras N. Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes. Diabetes. 2005;54:190–6.
Emmett M. Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle. Clin J Am Soc Nephrol. 2014;9:191–200.
Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q. Role of carnitine in disease. Nutr Metab. 2010;7:30.
Miranda-Massari JR, Gonzalez MJJ, Jimenez FJ, Allende-Vigo MZ, Duconge J. Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control. Curr Clin Pharmacol. 2011;6:260–73.
Qu H, Guo M, Chai H, Wang WT, Ga ZY, Shi DZ. Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7:e009835.
Hernández-Camacho JD, Bernier M, López-Lluch G, Navas P. Coenzyme Q10 supplementation in aging and disease. Front Physiol. 2018;9:44.
Lapin IP, Oxenkrug GF. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet. 1969;293:132–6.
Martin SL, Power A, Boyle Y, Anderson IM, Silverdale MA, Jones AKP. 5-HT modulation of pain perception in humans. Psychopharmacology. 2017;234:2929–39.
Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol. 2006;80:53–83.
Bannister K, Dickenson AH. What do monoamines do in pain modulation? Curr Opin Support Palliat Care. 2016;10:143–8.
Kim H, Chen L, Lim G, et al. Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. UEG Week 2013 Oral Presentations. J Clin Invest. 2013;2012(122):2940–54.
Dantzer R, O’Connor JC, Lawson MA, Kelley KW. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. 2011;36:426–36.
Dantzer R. Role of the kynurenine metabolism pathway in inflammation-induced depression: preclinical approaches. Curr Top Behav Neurosci. 2017;31:117–38.
de Oliveira FR, Fantucci MZ, Adriano L, et al. Neurological and inflammatory manifestations in Sjögren's syndrome: the role of the kynurenine metabolic pathway. Int J Mol Sci. 2018;19:3953.
Savitz J. The kynurenine pathway: a finger in every pie. Mol Psychiatry. 2020;25:131–47.
Hoffbrand AE. Megaloblastic Anemias. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison’s principles of internal medicine, 20 edition AccessMedicine. New York: McGraw-Hill Medical; 2018. chap. 95.
Oberlin BS, Tangney CC, Gustashaw KAR, Rasmussen HE. Vitamin B12 deficiency in relation to functional disabilities. Nutrients. 2013;5:4462–75.
Briani C, Torre CD, Citton V, et al. Cobalamin deficiency: clinical picture and radiological findings. Nutrients. 2013;5:4521–39.
Metin O, Özcan Ö, Gültepe M, Tekeli H, Güney M. Functional vitamin B12 deficiency represented by elevated urine methylmalonic acid levels in patients with migraine. Turk J Med Sci. 2008;38:409–14.
Levenson JL, editor. American Psychiatric Publishing textbook of psychosomatic medicine. 3rd ed. Arlington, VA: American Psychiatric Publishing; 2018.
Breecher MM, Dworken AM. In: Berkow R, editor. The Merck Manual. Medical Heritage, vol 2. New Jersey: Merck and Co.;1986. p. 229–321.
Nucifora LG, Tanaka T, Hayes LN, et al. Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry. Transl Psychiatry. 2017;7:e1215.
Diniz BS, Mendes-Silva AP, Silva LB, et al. Oxidative stress markers imbalance in late-life depression. J Psychiatr Res. 2018;102:29–33.
Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress. 2008;11:198–209.
Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses. 2003;61:519–25.
Stone TW, Perkins MN. Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol. 1981;72:411–2.
Cowen R, Stasiowska MK, Laycock H, Bantel C. Assessing pain objectively: the use of physiological markers. Anaesthesia. 2015;70:828–47.
Ummer K, Noone M. Prevalence of B12 deficiency in patients presenting with non-specific pain and other sensory symptoms: a clinical observational study (P3.307). Neurology. 2015;84(14 Supplement):p3.307.
Huang L, Ou R, de Souza RG, et al. Virus infections incite pain hypersensitivity by inducing indoleamine 2,3 dioxygenase. PLoS Pathog. 2016;12:e1005615.
Emmanuele V, López LC, Berardo A, et al. Heterogeneity of coenzyme Q 10 deficiency: patient study and literature review. Arch Neurol. 2012;69:978–83.
Sagalajev B, Wei H, Chen Z, Albayrak I, Koivisto A, Pertovaara A. Oxidative stress in the amygdala contributes to neuropathic pain. Neuroscience. 2018;387:92–103.
Batooei M, Roudsari AT, Basiri Z, et al. Evaluating the effect of oral N-acetylcysteine as an adjuvant treatment on clinical outcomes of patients with rheumatoid arthritis: a randomized, double-blind clinical trial. Rev Recent Clin Trials. 2018;13:132–8.
Chiu CK, Low TH, Tey YS, Singh VA, Shong HK. The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial. Singap Med J. 2011;52:868–73.
Magaña-Villa MC, Rocha-González HI, Fernández Del Valle-Laisequilla C, et al. B-vitamin mixture improves the analgesic effect of diclofenac in patients with osteoarthritis: a double blind study. Drug Res (Stuttg). 2013;63:289–92.
Geller M, Mibielli MA, Nunes CP, da Fonseca ADS, Goldberg SW, Oliveira L. Comparison of the action of diclofenac alone versus diclofenac plus B vitamins on mobility in patients with low back pain. J Drug Assess. 2016;5:1–3.
Wang JY, Wu YH, Liu SJ, Lin YS, Lu PH. Vitamin B12 for herpetic neuralgia: a meta-analysis of randomised controlled trials. Complement Ther Med. 2018;41:277–82.
Derosa G, D’Angelo A, Maffioli P. Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study. Drug Des Devel Ther. 2019;13:3647–55.
Agathos E, Tentolouris A, Eleftheriadou I, et al. Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy. J Int Med Res. 2018;46:1779–90.